Modifiable factors associated with Huntington's disease progression in presymptomatic participants.
Andres Gil-SalcedoRenaud MassartLaurent Cleret de LangavantAnne-Catherine Bachoud-LeviPublished in: Annals of clinical and translational neurology (2024)
Reducing modifiable risk factors for HD is one way to support the presymptomatic population. A high level of education, low-to-moderate alcohol consumption, no smoking, and BMI control are likely to slow disease progression in this population.